For immediate release … Friday, February 13, 2015
Contact: Rich Higginson 908.213.1971; richard_higginson@fdu.edu 5 Pages
Fairleigh Dickinson University’s PublicMind finds United States healthcare professionals hold clear misperceptions on differences between “over-the-counter” (OTC) and dietary supplement products in general, and more specifically in the omega-3 category – among the most popular dietary supplements sold in the United States today.
PublicMind data highlight cause for increased awareness by consumers using omega-3 dietary supplements, on the heels of New York Attorney General (NYAG), U.S. Government Accountability Office (GAO) and U.S. Senator statements that herbal supplements may not contain key ingredients noted on their bottle labels. Earlier this month, four major retailers (GNC, Target, Walgreens and Wal-Mart) were cited by the NYAG as selling vitamins and supplements that did not contain the active ingredients listed on their labels.
“In light of recent reports on the actual content of dietary supplements sold at major retailers, it is important that healthcare professionals who may be confused about the appropriate use of dietary supplement omega-3 products take heed,” said Rich Higginson, Director of Consumer Research at PublicMind.
The PublicMind survey, conducted across a randomly selected sample of 200 U.S. physicians and 150 U.S. pharmacists, showed that less than half (41%) of these professionals correctly stated that OTC products are regulated and approved by the U.S. Food and Drug Administration (FDA), while dietary supplement products are not.
Survey respondents demonstrated a number of additional misperceptions about the distinction between OTC and dietary supplement products, their appropriate use in patients, and clinical guidance regarding their use including a:
“Dietary supplements are not regulated by the U.S. Food and Drug Administration for content, safety or manufacturing processes,” said Higginson. “With confusion among health care professionals it is likely this may be even more confusing to patients. Consumers may not know that there are no OTC omega-3s – only supplements or prescription products.”
Methodology
The Fairleigh Dickinson University PublicMind poll, supported by Amarin Corporation, was an independent analysis of 350 U.S. healthcare professionals (including 200 physicians and 150 pharmacists). The study was conducted across the U.S. by telephone from February 20 through March 8, 2013.
Methodology, questions, and tables on the web at: http://publicmind.fdu.edu
Radio actualities at 201.692.2846 For more information, please call 201.692.7032
The most recent survey by Fairleigh Dickinson University’s PublicMind was conducted by telephone from February 20 through March 8, 2013, using a randomly selected sample of 200 physicians (including 150 primary care physicians (PCPs) and 50 cardiologists), and 150 pharmacists (including 75 employed by independent pharmacies and 75 by chain pharmacies), licensed and practicing across the United States.
PublicMind interviews are conducted by Opinion America of Cedar Knolls, NJ, with professionally trained interviewers using a CATI (Computer Assisted Telephone Interviewing) system. Random selection is achieved by computerized random-digit dialing of physicians and pharmacists drawn from a targeted sample list obtained using list sources from InfoUSA and Medi-Pro. This technique gives every physician and pharmacist in these databases an equal chance of being selected.
Table 1a: Professional Type:
Are you a…? |
|
|
Total |
Physician (Total) |
200 |
PCP |
150 |
Cardiologist |
50 |
Pharmacist (Total) |
150 |
Chain |
75 |
Independent |
75 |
Table 1: Recommend Dietary Supplements
In the past 12 months have you recommended any Dietary Supplements to any of your patients for abnormally high cholesterol or triglycerides |
|||
|
Total |
Physician |
Pharmacist |
Yes |
68% |
78% |
55% |
No |
32% |
22% |
45% |
Table 2: Differences between Dietary Supplements and OTC Drugs (Top Responses Shown)
To the best of your knowledge, in general terms, what differences, if any, exist between Over-the-Counter drugs and Dietary Supplements? (Open Ended Question) |
|||
|
Total |
Physician |
Pharmacist |
Dietary Supplements are not regulated by FDA |
24% |
21% |
28% |
No Difference |
11% |
17% |
2% |
FDA regulates OTC drugs |
10% |
10% |
9% |
FDA approves OTC Drugs |
7% |
4% |
11% |
Dietary supplements may not make health claims |
4% |
5% |
4% |
Don’t Know |
14% |
14% |
15% |
Table 3: Have Patients Requested Non-Prescription Omega 3
In the past 12 months, have any of your patients with abnormal cholesterol and/or abnormally high triglycerides indicated a desire to take non-prescription Omega-3? |
|||
|
Total |
Physician |
Pharmacist |
Yes |
83% |
87% |
77% |
No |
17% |
13% |
23% |
Table 4: Do You Typically Recommend Non-Prescription Omega 3
And in those instances do you typically recommend a non-prescription Omega-3, or not? |
|||
|
Total |
Physician |
Pharmacist |
Yes |
82% |
77% |
89% |
No |
18% |
23% |
11% |
Table 5: Ever Recommended Non-Prescription Omega 3 (Asked of those Saying ‘No’Above)
In the past 12 months have you recommended the use of a non-prescription Omega-3 to any of your patients for their abnormally high triglycerides? |
|||
|
Total |
Physician |
Pharmacist |
Yes |
43% |
45% |
40% |
No |
57% |
55% |
60% |
Table 6: Type of Omega-3 Recommended
Would that have been an over-the-counter Omega-3 product, a dietary supplement Omega-3, or both? |
|||
|
Total |
Physician |
Pharmacist |
OTC |
61% |
50% |
79% |
Dietary Supplement |
14% |
17% |
11% |
Both |
24% |
33% |
11% |
Table 7: Type of Omega-3 Recommended
And are non-prescription Omega-3s similar in strength and content to prescription Omega-3s? |
|||
|
Total |
Physician |
Pharmacist |
Yes |
25% |
22% |
30% |
No |
62% |
62% |
62% |
Not Sure |
12% |
16% |
8% |
Exact Question Wording
Introduction and Screening Questions Not Included in Release
Q1. First, we have you listed as a (INSERT TYPE), is that correct?
Primary Care Physician |
1 |
CONTINUE |
Cardiologist |
2 |
|
Pharmacist (Ask if Chain or Independent) |
3 |
|
If Other , TERMINATE |
4 |
|
Q2 Not Included in Release
Q3. In the past 12 months have you recommended any Dietary Supplements to any of your patients for abnormally high cholesterol or triglycerides?
Yes
No
Q4. To the best of your knowledge, in general terms, what differences, if any, exist between Over-the-Counter drugs and Dietary Supplements? (DO NOT READ PRE-CODES)
FDA regulates Over-the-Counter drugs
FDA approves Over-the-Counter Drugs
Dietary Supplements are not regulated by FDA
Dietary Supplements are not used to treat disease
Dietary supplements may not make health claims
Other (Specify___________)
Don’t Know
Q5-7 Not Included in Release
Q8. In the past 12 months, have any of your patients with abnormal cholesterol and/or abnormally high triglycerides indicated a desire to take non-prescription Omega-3?
Yes
No (SKIP TO Q10)
Q9. And in those instances do you typically recommend a non-prescription Omega-3, or not?
Recommend
Do Not Recommend
Q10. In the past 12 months have you recommended the use of a non-prescription Omega-3 to any of your patients for their abnormally high triglycerides?
Yes
No (SKIP TO Q13)
Q10a. Would that have been an over-the-counter Omega-3 product, a dietary supplement Omega-3, or both?
OTC
Dietary Supplement
Both
Q11-14 Not Included in Release
Q 15. And are non-prescription Omega-3s similar in strength and content to prescription Omega-3s?
Yes
No
Unsure
Q16-25 Not Included in Release
Thank you very much for time and input today, those are all my questions. Once again, I would like to assure you that all your responses will remain confidential.